Evidence map›Paper›PMID 36483391›Full record

ArticleAntimicrobial stewardship & healthcare epidemiology : ASHE2022

A national study of antibiotic use in Greek pediatric hematology oncology and bone marrow transplant units.

Elpis Mantadakis, Ioannis Kopsidas, Susan Coffin, Gabriel Dimitriou, Despoina Gkentzi, Emmanouel Hatzipantelis, Aikaterini Kaisari, Antonis Kattamis, Eleni Kourkouni, Smaragda Papachristidou and 9 more

Open access · goldAbstract read
In one paragraph

Article in Antimicrobial stewardship & healthcare epidemiology : ASHE, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 2 countries.

Elpis MantadakisDemocritus University of Thrace Faculty of Medicine, University General Hospital of Alexandroupolis, Alexandroupolis, Greece.ORCID https://orcid.org/0000-0001-7837-9733
Ioannis KopsidasCenter for Clinical Epidemiology and Outcomes Research (CLEO), Athens, Greece.ORCID https://orcid.org/0000-0001-6499-4807
Susan CoffinDivision of Infectious Diseases and Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States.ORCID https://orcid.org/0000-0001-9566-5600
Gabriel DimitriouPatras Medical School, University General Hospital of Patras, Patra, Greece.ORCID https://orcid.org/0000-0001-7929-1573
Despoina GkentziPatras Medical School, University General Hospital of Patras, Patra, Greece.ORCID https://orcid.org/0000-0002-1421-0813
Emmanouel HatzipantelisChildren & Adolescent Hematology-Oncology Unit, Second Pediatric Department, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.ORCID https://orcid.org/0000-0002-7535-2970
Aikaterini KaisariStem Cell Transplant Unit, Aghia Sophia Children's Hospital, Athens, Greece.ORCID https://orcid.org/0000-0002-5561-0397
Antonis KattamisFirst Department of Pediatrics, National and Kapodistrian University of Athens, Aghia Sophia Children's Hospital, Athens, Greece.ORCID https://orcid.org/0000-0002-5178-0655
Eleni KourkouniCenter for Clinical Epidemiology and Outcomes Research (CLEO), Athens, Greece.
Smaragda PapachristidouOncology Department, "P & A Kyriakou" Children's Hospital, Athens, Greece.
Evgenia PapakonstantinouDepartment of Pediatric Oncology, Hipppokration General Hospital, Thessaloniki, Greece.ORCID https://orcid.org/0000-0001-5620-7885
Sophia PolychronopoulouDepartment of Pediatric Hematology-Oncology (T.A.O.), Aghia Sophia Children's Hospital, Athens, Greece.ORCID https://orcid.org/0000-0001-9716-9264
Emmanuel RoilidesThird Department of Pediatrics, Aristotle University of Thessaloniki, Hipppokration General Hospital, Thessaloniki, Greece.ORCID https://orcid.org/0000-0002-0202-364X
Nikos SpyridisInfectious Diseases Unit, Second Department of Pediatrics, National and Kapodistrian University of Athens (NKUA), Athens, Greece.ORCID https://orcid.org/0000-0002-1403-5699
Sotirios TsiodrasFourth Department of Internal Medicine, National and Kapodistrian University of Athens, Attikon Hospital, Athens, Greece.ORCID https://orcid.org/0000-0002-0463-4321
Maria N TsoliaInfectious Diseases Unit, Second Department of Pediatrics, National and Kapodistrian University of Athens (NKUA), Athens, Greece.ORCID https://orcid.org/0000-0003-2485-4409
Grammatiki-Christina TsopelaCenter for Clinical Epidemiology and Outcomes Research (CLEO), Athens, Greece.ORCID https://orcid.org/0000-0003-3662-0140
Theoklis ZaoutisCenter for Clinical Epidemiology and Outcomes Research (CLEO), Athens, Greece.
Athanasios TragiannidisChildren & Adolescent Hematology-Oncology Unit, Second Pediatric Department, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.ORCID https://orcid.org/0000-0003-4294-2605
National and Kapodistrian University of Athens · GRAristotle University of Thessaloniki · GRChildren's Hospital Agia Sophia · GRGeneral University Hospital of Patras · GRChildren's Hospital of Philadelphia · USDemocritus University of Thrace · GRPanagiotis & Aglaia Kyriakou Children's Hospital · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: We surveyed antimicrobials used in Greek pediatric hematology-oncology (PHO) and bone marrow transplant (BMT) units before and after an intervention involving education regarding the 2017 clinical practice guidelines (CPG) for the management of febrile neutropenia in children with cancer and hematopoietic stem-cell transplant recipients. Design: Antibiotic prescribing practices were prospectively recorded between June 2016 and November 2017. Intervention: In December 2017, baseline data feedback was provided, and CPG education was provided. Prescribing practices were followed for one more year. For antibiotic stewardship, days of therapy, and length of therapy were calculated. Setting: Five of the 6 PHO units in Greece and the single pediatric BMT unit participated. Participants: Admitted children in each unit who received the first 15 new antibiotic courses each month. Results: Administration of ≥4 antibiotics simultaneously and administration of antibiotics with overlapping activity for ≥2 days were significantly more common in PHO units in general hospitals compared to children's hospitals. Use of at least 1 antifungal was recorded in ∼47% of the patients before and after the intervention. De-escalation and/or discontinuation of antibiotics on day 6 of initial treatment increased significantly from 43% to 53.5% (P = .032). Although the number of patients requiring intensive care support for sepsis did not change, a significant drop was noted in all-cause mortality (P = .008). Conclusions: We recorded the antibiotic prescribing practices in Greek PHO and BMT units, we achieved improved prescribing with a simple intervention, and we identified areas in need of improvement.

Identifiers

PMID36483391
PMCPMC9726537
OpenAlexW4226133617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.